NCIt definition : An anti-glypican 3 (GPC3; GPC-3)/anti-CD3 bispecific monoclonal antibody, with potential
immunostimulating and antineoplastic activities. Anti-GPC3/CD3 bispecific antibody
ERY974 possesses two antigen-recognition and binding sites, one for the CD3 complex,
a group of T-cell surface glycoproteins that complex with the T-cell receptor (TCR),
and one for GPC3, a tumor-associated antigen (TAA) overexpressed on the surface of
certain tumor cells. Upon administration of ERY974, this bispecific antibody simultaneously
binds to both CD3-expressing and GPC3-expressing cells, thereby crosslinking GPC3-expressing
tumor cells and cytotoxic T-lymphocytes (CTLs). This may result in potent CTL-mediated
lysis of GPC3-expressing tumor cells. GPC3, a heparan sulfate proteoglycan and an
oncofetal antigen protein, is overexpressed in a variety of cancers; it plays a role
in cell division and growth regulation.;
Semantic type(s)